Lavaca Capital’s CME Group CME Stock Holding History

Lavaca Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.5K	Hold	39	–	–	﹤0.01%	246
2025 Q4	$10.7K	Buy	39 +4	+11%	+$1.09K	﹤0.01%	253
2025 Q3	$9.46K	Buy	+35	New	+$9.52K	﹤0.01%	243

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lavaca Capital's CME Position: Q1 2026 in Review

Lavaca Capital held its CME Group (CME) position steady in Q1 2026 at 39 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #246.

Lavaca Capital first reported a position in CME in Q3 2025 and has held it in 3 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Lavaca Capital held 39 shares of CME Group worth $11.5K as of Q1 2026.
Lavaca Capital left its CME Group share count unchanged in Q1 2026.
CME Group made up ﹤0.01% of Lavaca Capital's portfolio in Q1 2026, its #246 holding.
Lavaca Capital first reported a position in CME Group in Q3 2025 and has held it in 3 quarters since.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.